← Back to Search

Behavioural Intervention

Dieta mobile application for Encephalopathy

N/A
Waitlist Available
Led By Douglas Simonetto, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial will test if a mobile app can help treat hepatic encephalopathy by measuring stool to see if the person needs more or less lactulose.

Eligible Conditions
  • Liver Encephalopathy

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Achievement of daily stool goal

Trial Design

1Treatment groups
Experimental Treatment
Group I: Mobile application-based Bristol stool scaleExperimental Treatment1 Intervention
Subjects with cirrhosis who are taking lactulose for the treatment of hepatic encephalopathy will download the Dieta mobile application on their mobile device and take a photo of each bowel movement using the Dieta application

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,205 Previous Clinical Trials
3,766,734 Total Patients Enrolled
Douglas Simonetto, MDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
440 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still positions available for participants in this experiment?

"Based on the information found clinicaltrials.gov, this particular trial has stopped its search for participants as of November 29th 2022. Initially posted on September 14th 2022 it is now one among 140 other related studies that are actively recruiting patients at present."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Prevention of Hepatic Encephalopathy With Mobile Application Based Lactulose Titration
Douglas (Doug) A. Simonetto 2022. "Prevention of Hepatic Encephalopathy With Mobile Application Based Lactulose Titration". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05526404.
~19 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top